These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2312735)

  • 101. The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
    Di Leo E; Eminoglu T; Magnolo L; Bolkent MG; Tümer L; Okur I; Tarugi P
    J Clin Lipidol; 2015; 9(3):400-5. PubMed ID: 26073401
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Fatty liver in a case with heterozygous familial hypobetalipoproteinemia.
    Ogata H; Akagi K; Baba M; Nagamatsu A; Suzuki N; Nomiyama K; Fujishima M
    Am J Gastroenterol; 1997 Feb; 92(2):339-42. PubMed ID: 9040220
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Familial hypobetalipoproteinemia.
    Linton MF; Farese RV; Young SG
    J Lipid Res; 1993 Apr; 34(4):521-41. PubMed ID: 8496659
    [No Abstract]   [Full Text] [Related]  

  • 104. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.
    Chan L
    J Biol Chem; 1992 Dec; 267(36):25621-4. PubMed ID: 1464582
    [No Abstract]   [Full Text] [Related]  

  • 105. Familial hypobetalipoproteinemia. Absence of atherosclerosis in a postmortem study.
    Kahn JA; Glueck CJ
    JAMA; 1978 Jul; 240(1):47-8. PubMed ID: 207903
    [No Abstract]   [Full Text] [Related]  

  • 106. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
    Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
    Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Acanthocytosis in a patient with homozygous familial hypobetalipoproteinemia due to a novel APOB splice site mutation.
    Hegele RA; Miskie BA
    Clin Genet; 2002 Feb; 61(2):101-3. PubMed ID: 11940084
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Identification and characterization of truncated forms of apolipoprotein B in hypobetalipoproteinemia.
    Young SG; Krul ES; McCormick S; Farese RV; Linton MF
    Methods Enzymol; 1996; 263():120-45. PubMed ID: 8749004
    [No Abstract]   [Full Text] [Related]  

  • 109. Heterozygous hypobetalipoproteinemia with fasting chylomicronemia.
    Huet G; Dieu MC; Martin A; Grard G; Bard JM; Fossati P; Degand P
    Clin Chem; 1991 Feb; 37(2):296-300. PubMed ID: 1993347
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia.
    Clarke MW; Hooper AJ; Headlam HA; Wu JH; Croft KD; Burnett JR
    Clin Chem; 2006 Jul; 52(7):1339-45. PubMed ID: 16728468
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Novel APOB mutation in familial hypobetalipoproteinemia.
    Domenech M; Llano-Rivas I; Arroyo V; Ortega E
    J Clin Lipidol; 2022; 16(1):28-32. PubMed ID: 34852964
    [No Abstract]   [Full Text] [Related]  

  • 112. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism.
    Beil FU; Fojo SS; Brewer HB; Greten H; Beisiegel U
    Eur J Clin Invest; 1992 Feb; 22(2):88-95. PubMed ID: 1349286
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Familial hypobetalipoproteinemia: a review.
    Schonfeld G
    J Lipid Res; 2003 May; 44(5):878-83. PubMed ID: 12639976
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred.
    Friedl W; Ludwig EH; Balestra ME; Arnold KS; Paulweber B; Sandhofer F; McCarthy BJ; Innerarity TL
    Arterioscler Thromb; 1991; 11(2):371-8. PubMed ID: 1671822
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Novel mutation (c.G1124A) in exon 9 of the APOB gene causes aberrant splicing and familial hypobetalipoproteinemia.
    Homer VM; George PM
    Clin Chem; 2007 Jun; 53(6):1165-7. PubMed ID: 17517592
    [No Abstract]   [Full Text] [Related]  

  • 116. Insights into apolipoprotein B biology from transgenic and gene-targeted mice.
    Véniant MM; Kim E; McCormick S; Borén J; Nielsen LB; Raabe M; Young SG
    J Nutr; 1999 Feb; 129(2S Suppl):451S-455S. PubMed ID: 10064308
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.
    Le R; Zhao L; Hegele RA
    J Clin Lipidol; 2022; 16(2):155-159. PubMed ID: 35221233
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
    Rimbert A; Vanhoye X; Coulibaly D; Marrec M; Pichelin M; Charrière S; Peretti N; Valéro R; Wargny M; Carrié A; Lindenbaum P; Deleuze JF; Genin E; Redon R; Rollat-Farnier PA; Goxe D; Degraef G; Marmontel O; Divry E; Bigot-Corbel E; Moulin P; Cariou B; Di Filippo M
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e63-e71. PubMed ID: 33207932
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Organ loci of catabolism of short truncations of apoB.
    Zhu XF; Noto D; Seip R; Shaish A; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1032-8. PubMed ID: 9194751
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Heterozygous apolipoprotein C-II deficiency: lipoprotein and apoprotein phenotype and RsaI restriction enzyme polymorphism in the Apo C-IIPadova kindred.
    Gabelli C; Bilato C; Santamarina-Fojo S; Martini S; Brewer HB; Crepaldi G; Baggio G
    Eur J Clin Invest; 1993 Sep; 23(9):522-8. PubMed ID: 7902280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.